INVO Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 306.8%.

Top 21 shareholders own 14.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.34%	Sabby Management, LLC	231,023	US$378.9k	0%	0.97%
1.46%	Citadel Advisors LLC	36,194	US$59.4k	0%	no data
1.29%	AWM Investment Company Inc	32,000	US$52.5k	2.59%	0.01%
0.58%	Geode Capital Management, LLC	14,406	US$23.6k	230.49%	no data
0.31%	Andrea Goren	7,731	US$12.7k	3.62%	no data
0.24%	Steven Shum	5,919	US$9.7k	0%	no data
0.21%	The Vanguard Group, Inc.	5,276	US$8.7k	0%	no data
0.15%	Michael Campbell	3,678	US$6.0k	7.92%	no data
0.15%	Perritt Capital Management, Inc.	3,650	US$6.0k	0%	no data
0.11%	Tower Research Capital LLC	2,683	US$4.4k	453.2%	no data
0.079%	Matthew Szot	1,960	US$3.2k	0%	no data
0.068%	Trent Davis	1,682	US$2.8k	0%	no data
0.064%	Barbara Ryan	1,580	US$2.6k	0%	no data
0.046%	Rebecca Messina	1,150	US$1.9k	0%	no data
0.025%	Securities America Advisors, Inc.	609	US$998.8	0%	no data
0.022%	City National Rochdale, LLC	538	US$882.3	0%	no data
0.0046%	Aspire Private Capital, LLC	115	US$188.7	666.67%	no data
0.0017%	Morgan Stanley, Investment Banking and Brokerage Investments	41	US$67.4	-2.38%	no data
0.00097%	BlackRock, Inc.	24	US$39.4	4.35%	no data
0.00065%	Wells Fargo & Company, Private Banking and Investment Banking Arm	16	US$26.4	300%	no data
0.00012%	The Gleason Group, Inc.	3	US$4.9	0%	no data